Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;9(13):1103-1113.
doi: 10.2217/imt-2017-0091.

Melanoma: a prototype of cancer-testis antigen-expressing malignancies

Sepideh Faramarzi  1 , Soudeh Ghafouri-Fard  1
Affiliations
Review

Melanoma: a prototype of cancer-testis antigen-expressing malignancies

Sepideh Faramarzi et al. Immunotherapy. 2017 Oct.

Abstract

Melanoma is the first malignancy in which expression and immunogenicity of cancer-testis antigens (CTAs) have been documented. Several CTAs have been shown to be expressed in melanoma samples especially those with metastatic potential. Many of them have been shown to exert oncogenic effects through modulation of essential pathways involved in melanoma. The crucial role of CTAs in the pathogenesis of melanoma, the high prevalence of expression of CTA panels in melanoma and the presence of spontaneous as well as inducible immune responses against CTAs in melanoma patients potentiate CTAs as immunotherapeutic targets. Numerous clinical trials are now ongoing to evaluate CTA-based immunotherapeutic effects in melanoma patient's survival. NY-ESO-1 and MAGE antigens have the most promising results up to now.

Keywords: cancer-testis antigen; immunotherapy; melanoma.

PubMed Disclaimer

LinkOut - more resources